登录 查看组织和合同定价。
选择尺寸
关于此项目
经验公式(希尔记法):
C28H35FO7
化学文摘社编号:
分子量:
502.57
UNSPSC Code:
41116107
PubChem Substance ID:
EC Number:
256-915-2
MDL number:
产品名称
安西奈德, analytical standard
InChI key
ILKJAFIWWBXGDU-MOGDOJJUSA-N
InChI
1S/C28H35FO7/c1-16(30)34-15-22(33)28-23(35-26(36-28)9-4-5-10-26)13-20-19-7-6-17-12-18(31)8-11-24(17,2)27(19,29)21(32)14-25(20,28)3/h8,11-12,19-21,23,32H,4-7,9-10,13-15H2,1-3H3/t19-,20-,21-,23+,24-,25-,27-,28+/m0/s1
SMILES string
[H][C@@]12C[C@@]3([H])[C@]4([H])CCC5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@@]1(OC6(CCCC6)O2)C(=O)COC(C)=O
grade
analytical standard
technique(s)
HPLC: suitable
gas chromatography (GC): suitable
application(s)
forensics and toxicology
veterinary
format
neat
Quality Level
Gene Information
human ... NR3C1(2908)
正在寻找类似产品? 访问 产品对比指南
Application
Refer to the product′s Certificate of Analysis for more information on a suitable instrument technique. Contact Technical Service for further support.
General description
Amcinonide is a highly potent topical corticosteroid. It possesses pharmacological properties like anti-pruritic, anti-inflammatory and vasoconstrictive activity.
存储类别
13 - Non Combustible Solids
wgk
WGK 2
flash_point_f
Not applicable
flash_point_c
Not applicable
ppe
Eyeshields, Gloves, type N95 (US)
法规信息
涉药品监管产品
此项目有
G Rivara et al.
Contact dermatitis, 21(2), 83-91 (1989-08-01)
22 cases of allergic contact dermatitis from topical corticosteroids were observed in Strasbourg and previously published. 7 further cases are reported here and the vehicle and concentration of corticosteroids for patch tests are discussed. A 0.1% concentration in petrolatum seemed
Exacerbation of allergic contact dermatitis from amcinonide triggered by patch testing.
D Sasseville
Contact dermatitis, 45(4), 232-233 (2001-10-31)
Allergic contact dermatitis due to amcinonide.
R Hayakawa et al.
Contact dermatitis, 23(1), 49-50 (1990-07-01)
Contact dermatitis from budesonide in a nasal spray without cross-reactivity to amcinonide.
P M Gamboa et al.
Contact dermatitis, 24(3), 227-228 (1991-03-01)
R C Cornell
Cutis, 31(5), 566-569 (1983-05-01)
Thirty-nine patients with psoriasis were treated either with amcinonide ointment 0.1 percent twice a day or with fluocinonide ointment 0.05 percent three times a day in a two-week, randomized, parallel-group, double-blind study. The severities of the skin lesions at baseline
我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持